Corvus Pharmaceuticals, Inc. — Director's Dealing 2018

Mar 13, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Corvus Pharmaceuticals, Inc. (CRVS)
CIK: 0001626971
Period of Report: 2018-03-12

Reporting Person: Novo Holdings A/S (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-03-12	COMMON STOCK	P	1176470	$8.50	Acquired	4420516	Direct

Footnotes

F1: Represents a purchase from the underwriters in the Issuer's secondary offering.